Logo image of WGRX

WELLGISTICS HEALTH INC (WGRX) Stock Fundamental Analysis

NASDAQ:WGRX - Nasdaq - US9495031067 - Common Stock - Currency: USD

0.92  -0.09 (-8.91%)

After market: 0.92 0 (0%)

Fundamental Rating

0

Overall WGRX gets a fundamental rating of 0 out of 10. We evaluated WGRX against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of WGRX have multiple concerns. WGRX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WGRX had negative earnings in the past year.
In the past year WGRX has reported a negative cash flow from operations.
WGRX Yearly Net Income VS EBIT VS OCF VS FCFWGRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -67.52%, WGRX is doing worse than 92.23% of the companies in the same industry.
WGRX's Return On Equity of -875.32% is on the low side compared to the rest of the industry. WGRX is outperformed by 83.50% of its industry peers.
Industry RankSector Rank
ROA -67.52%
ROE -875.32%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WGRX Yearly ROA, ROE, ROICWGRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

The Gross Margin of WGRX (8.49%) is worse than 77.67% of its industry peers.
WGRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WGRX Yearly Profit, Operating, Gross MarginsWGRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10 -20 -30

More info and screens

1

2. Health

2.1 Basic Checks

WGRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WGRX has less shares outstanding
Compared to 1 year ago, WGRX has an improved debt to assets ratio.
WGRX Yearly Shares OutstandingWGRX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
WGRX Yearly Total Debt VS Total AssetsWGRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

WGRX has an Altman-Z score of -2.44. This is a bad value and indicates that WGRX is not financially healthy and even has some risk of bankruptcy.
WGRX has a Altman-Z score of -2.44. This is amonst the worse of the industry: WGRX underperforms 86.41% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that WGRX has dependencies on debt financing.
WGRX has a Debt to Equity ratio of 1.43. This is in the lower half of the industry: WGRX underperforms 67.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -2.44
ROIC/WACCN/A
WACC7.93%
WGRX Yearly LT Debt VS Equity VS FCFWGRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 5M 10M

2.3 Liquidity

WGRX has a Current Ratio of 0.36. This is a bad value and indicates that WGRX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of WGRX (0.36) is worse than 93.20% of its industry peers.
WGRX has a Quick Ratio of 0.36. This is a bad value and indicates that WGRX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of WGRX (0.15) is worse than 93.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.15
WGRX Yearly Current Assets VS Current LiabilitesWGRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for WGRX have decreased strongly by -160.04% in the last year.
EPS 1Y (TTM)-160.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WGRX Yearly Revenue VS EstimatesWGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WGRX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WGRX Price Earnings VS Forward Price EarningsWGRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WGRX Per share dataWGRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WGRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WELLGISTICS HEALTH INC

NASDAQ:WGRX (6/25/2025, 8:19:09 PM)

After market: 0.92 0 (0%)

0.92

-0.09 (-8.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-12 2025-05-12
Earnings (Next)09-08 2025-09-08
Inst Owners0.49%
Inst Owner ChangeN/A
Ins Owners55.06%
Ins Owner Change87.8%
Market Cap66.11M
AnalystsN/A
Price TargetN/A
Short Float %0.7%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.28
P/FCF N/A
P/OCF N/A
P/B 14.76
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.4
BVpS0.06
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.52%
ROE -875.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.49%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.15
Altman-Z -2.44
F-Score5
WACC7.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-113.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-358.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-250.9%
OCF growth 3YN/A
OCF growth 5YN/A